Tak Paul Peter

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$230,020.20
Insider Sells Quantity
2
Insider Sells Sum
$267,032.94

Insider Activity of Tak Paul Peter

According to the SEC Form 4 filings, Tak Paul Peter, being in a position of

  1. Chief Executive Officer at Candel Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 42821 share for $267,033,
    over all time since 2021-07-29, has bought 40985 shares for $230,020, and sold 42821 share for $267,033.

The largest purchase of all time was on 2021-07-29 and amounted to 25000 shares of Candel Therapeutics, Inc. for $200,000.

The largest sale of all time was on 2024-07-17 and amounted to 22528 shares of Candel Therapeutics, Inc. for $145,815.

Biography of Tak Paul Peter

No biography is available at this moment.

2024-07-17SaleCandel Therapeutics, Inc.
CADL
Chief Executive Officer
22,528
0.0746%
$6.47$145,815-7.61%
2024-07-11SaleCandel Therapeutics, Inc.
CADL
Chief Executive Officer
20,293
0.0713%
$5.97$121,2180%
2022-12-09PurchaseCandel Therapeutics, Inc.
CADL
Chief Executive Officer
12,935
0.0411%
$1.92$24,835-35.41%
2022-12-08PurchaseCandel Therapeutics, Inc.
CADL
Chief Executive Officer
3,050
0.0094%
$1.70$5,185-28.68%
2021-07-29PurchaseCandel Therapeutics, Inc.
CADL
Chief Executive Officer
25,000
0.1175%
$8.00$200,000-24.18%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.